The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


GLYPRESSIN 1 mg Powder and Solvent for Solution for Injection



Ferring Ireland LtdPA1009/004/001

Main Information

Trade NameGLYPRESSIN 1 mg Powder and Solvent for Solution for Injection
Active SubstancesTerlipressin acetate
Dosage FormPowder and solvent for solution for injection
Licence HolderFerring Ireland Ltd
Licence NumberPA1009/004/001

Group Information

ATC CodeH01BA Vasopressin and analogues
H01BA04 terlipressin

Status

License statusAuthorised
Licence Issued09/04/1987
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back